Just a moment, the page is loading...

ASTELLAS-015K-CL-RA22




A Phase 2b, Randomized, Double-blind, Parallel-group, Placebo-controlled, Dose-finding, Multi-center Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis Patients
peficitinib hydrobromide
015K-CL-RA22
NCT01565655
EudraCT 2011-006020-20
Rheumatoid Arthritis
Phase 2
February 2020